Yaba is a small, brightly colored tablet containing methamphetamine and caffeine. Each pill is roughly the size of a pencil eraser and typically contains 25 to 30 mg of methamphetamine and 45 to 65 mg of caffeine. The name translates loosely from Thai as “crazy medicine” or “madness drug,” and the tablets are primarily manufactured in Myanmar before being trafficked across Southeast Asia and beyond.
What’s Inside a Yaba Tablet
Methamphetamine makes up roughly 20 to 30% of each tablet, with caffeine accounting for 60 to 70%. The caffeine isn’t filler. It lowers the temperature at which methamphetamine vaporizes, making the drug easier to smoke. Some tablets also contain artificial flavors, giving them a candy-like taste that masks the chemical bitterness. The pills are usually reddish-orange or green, and most carry a stamped logo like “WY” or “R.”
Occasionally, yaba tablets have been found to contain heroin in varying proportions, making the contents of any given pill unpredictable.
How People Use It
The most common method is swallowing the tablet whole, which produces a slower onset and longer-lasting high. Many users, however, crush the tablets and heat the powder on aluminum foil, then inhale the vapor through a straw. This technique, similar to “chasing the dragon” with heroin, delivers methamphetamine to the brain much faster and produces a more intense rush. Some users also dissolve the tablets and inject the solution, though this is less common.
The route of administration matters. Smoking or injecting sends the drug to the brain in seconds, producing a sharp spike of euphoria that fades quickly and drives repeated dosing. Swallowing it creates a more gradual effect but still carries the same risks of dependence over time.
Effects on the Brain and Body
Methamphetamine floods the brain with dopamine, the chemical involved in reward, motivation, and pleasure. The result is an intense burst of energy, euphoria, and alertness that can last for hours. Caffeine reinforces these effects by further stimulating the central nervous system. In the short term, users feel more confident, talkative, and physically energized.
The other side of that coin arrives quickly. Heart rate and blood pressure spike. Body temperature rises. Users often can’t sleep or eat for extended periods. At higher doses or with repeated use, the drug can trigger paranoia, disordered thinking, and hallucinations. This methamphetamine-induced psychosis can make a person agitated and potentially dangerous to themselves or others, though it typically resolves within about a week after the person stops using.
Long-term use causes lasting changes in the brain’s dopamine system, leading to persistent depression, emotional instability, and difficulty experiencing pleasure from everyday activities. Cardiovascular damage accumulates over time as well, with chronic users facing elevated risks of heart problems and stroke.
Overdose Risks
Acute methamphetamine toxicity typically shows up as severe agitation, delirium, chest pain, dangerously high blood pressure, and overheating. Death from overdose most often involves the cardiovascular system. In one large dataset of methamphetamine-related deaths, 55% involved a cerebrovascular cause (such as stroke), 20% had a cardiac cause, and an additional 27% had significant cardiac conditions listed as contributing factors. Among cases with no specific secondary cause identified, fatal heart rhythm disturbances were considered the most likely explanation.
Because yaba’s methamphetamine content varies from tablet to tablet, and because some pills contain heroin or other adulterants, users have no reliable way to gauge a “safe” dose.
Withdrawal and What It Feels Like
Withdrawal symptoms begin within 24 hours of the last dose and peak over the first three to five days. During this acute phase, people commonly experience agitation, irritability, depression, muscle aches, increased sleeping, and a surge in appetite. One case report from Northeast India documented a 34-year-old man whose withdrawal involved intense abdominal pain radiating to his back, nausea, body aches, low mood, reduced concentration, and loss of appetite.
After the acute phase passes, a protracted withdrawal period lasting one to two months is common. This stage is characterized by lingering fatigue, anxiety, unstable emotions, erratic sleep, and strong cravings. The low mood and loss of interest in daily activities can persist for weeks, sometimes requiring additional support to manage.
Treatment for Yaba Addiction
No single medication is approved specifically for methamphetamine dependence, but several approaches have shown promise in clinical trials. Cognitive behavioral therapy remains the backbone of treatment, helping people identify triggers and develop coping strategies. When combined with medication, outcomes tend to improve.
In one 16-week trial combining a wakefulness-promoting medication with cognitive behavioral therapy, 60% of participants who completed the program reduced their methamphetamine use by more than half. Other trials have found that certain antidepressants and opioid-blocking medications can reduce use and dampen cravings. Replacement-style approaches, where a milder, controlled stimulant is prescribed to ease the transition off methamphetamine, have also shown early positive results, including better treatment retention and lower levels of dependence.
Recovery is realistic but rarely quick. The protracted withdrawal phase, with its emotional instability and persistent cravings, is the period when relapse risk is highest. Structured support during those first two months makes a meaningful difference.
Legal Status
In the United States, methamphetamine is a Schedule II controlled substance, meaning it has a high potential for abuse and can lead to severe psychological or physical dependence. Yaba is classified under this same schedule because its active ingredient is methamphetamine. Possession, distribution, or manufacturing carries serious federal penalties. The DEA lists “yaba” as one of the recognized street names for methamphetamine.
Internationally, methamphetamine is controlled under the 1971 Convention on Psychotropic Substances, which covers stimulants, depressants, and hallucinogens. Countries across Southeast Asia, where yaba use is most widespread, have imposed their own strict penalties. Thailand, which gave the drug its name, classifies it as a Category 1 narcotic with some of the harshest drug laws in the region.